Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment

Background: The antitumor and immunomodulating activities of melatonin are widely known. These activities are based upon the multifactorial mechanism of action on various links of carcinogenesis. In the present paper, the long-term results of the clinical use of melatonin in the combined treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zharinov, Gennady M., Bogomolov, Oleg A., Chepurnaya, Irina V., Neklasova, Natalia Yu., Anisimov, Vladimir N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566809/
https://www.ncbi.nlm.nih.gov/pubmed/33110479
http://dx.doi.org/10.18632/oncotarget.27757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566809/
https://www.ncbi.nlm.nih.gov/pubmed/33110479
http://dx.doi.org/10.18632/oncotarget.27757

Ejemplares similares